News - Endo Pharmaceuticals


Current filters:

Endo Pharmaceuticals

Popular Filters

Endo completes sale of early-stage drug discovery portfolio

Endo completes sale of early-stage drug discovery portfolio


Ireland-headquartered Endo Pharmaceuticals has completed the sale of its branded pharmaceutical drug…

AsanaBioSciencesEndo PharmaceuticalsMergers & AcquisitionsPharmaceutical

Endo to buy Mexican specialty pharma company Somar


USA-based Endo International as entered into a definitive agreement to acquire Grupo Farmaceutico Somar,…

Endo PharmaceuticalsGenericsMergers & AcquisitionsMexicoSouth America

US Judge enforces settlement deal between Mylan and Endo over generic Frova

US Judge enforces settlement deal between Mylan and Endo over generic Frova


US generic major Mylan today confirmed that a federal district court has granted its request to enforce…

Endo Health SolutionsEndo PharmaceuticalsFrovaGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsUSA

Endo’s testosterone replacement Aveed gets FDA approval

Endo’s testosterone replacement Aveed gets FDA approval


Endo International says its operating company Endo Pharmaceuticals has received US Food and Drug Administration…

AveedEndo PharmaceuticalsMen's HealthNorth AmericaPharmaceuticalRegulationUSA

Mersana Therapeutics reaches second preclinical milestone in Endo collaboration


Privately-held US biotech company Mersana Therapeutics has achieved its second preclinical milestone…

BiotechnologyEndo PharmaceuticalsFinancialLicensingMersanaOncologyResearchUSA

Endo Pharma gets CTL from FDA relating to testosterone drug Aveed


response letter (CRL) regarding the New Drug Application (NDA) for subsidiary Endo Pharmaceuticals' long-acting…

AveedEndo Health SolutionsEndo PharmaceuticalsMen's HealthNorth AmericaPharmaceuticalRegulationTestosterone

US FDA to allow generic copies of Endo's Opana


Endo Health Solutions (Nasdaq: ENDP) announced Friday (May 10) that the US Food and Drug Administration…

Endo Health SolutionsEndo PharmaceuticalsGenericsNeurologicalNorth AmericaOpana ERPharmaceuticalRegulation

Actavis confirms patent challenge to Endo's Fortesta


Generics drug giant Actavis (NYSE: ACT, formerly trading as Watson) has confirmed filing an Abbreviated…

ActavisEndo PharmaceuticalsFortestaGenericsMen's HealthNorth AmericaPatentsRegulation

Endo fails in FDA law suit to stop generic Opana ER in USA; Mylan settles with Orion


The US District Judge Reggie Walton, of the District Court for the District of Columbia, has dismissed…

ActavisComtanEndo PharmaceuticalsGenericsImpax LaboratoriesLegalMylan LaboratoriesNeurologicalNorth AmericaOpana ERPharmaceutical

US patent settlements of Xopenex and Lidoderm


US generics drug major Mylan (Nasdaq: MYL) has entered into a settlement agreement with Sunovion Pharmaceuticals,…

Dainippon Sumitomo PharmaEndo PharmaceuticalsGenericsLidodermMylan LaboratoriesNeurologicalNorth AmericaPatentsRespiratory and PulmonarySunovionWatson PharmaceuticalsXopenex

Mersana inks ADC deal with Endo Pharma


Privately-held Mersana Therapeutics has joined the antibody-drug conjugate space, announcing its first…

BiotechnologyEndo PharmaceuticalsLicensingMersanaOncology

Endo Pharma in $180 million deal with BioDelivery Sciences


US drugmaker Endo Pharmaceuticals (Nasdaq: ENDP) has signed a worldwide license and development agreement…

BioDelivery SciencesBuprenorphineEndo PharmaceuticalsLicensingNeurologicalPharmaceutical

Endo Pharma pulls out of axomadol deal with Grunenthal


USA-based Endo Pharmaceuticals (Nasdaq: ENDP) says that it is terminating its research program and collaboration…

axomadolEndo PharmaceuticalsGrunenthalLicensingNeurologicalPharmaceuticalResearch

Endo Pharma sues Mylan over Frova patent infringement


US generic drugmaker Mylan (Nasdaq: MYL) yesterday confirmed that the company and its subsidiary Mylan…

Endo PharmaceuticalsFrovaFrovatriptan SuccinateGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaRegulation

Back to top